Current Net Margin
-4132.24%
Stoke Therapeutics, Inc. currently has a net profit margin of -4132.24%.
Financial Fundamentals
STOK • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.06 | -4132.24% | ▼377156 |
| 2025-09-30 | 0.01 | -0.04 | -360.68% | ▼19072 |
| 2025-06-30 | 0.01 | -0.02 | -169.96% | ▼24114 |
| 2025-03-31 | 0.16 | 0.11 | 71.19% | ▲11754 |
| 2024-12-31 | 0.02 | -0.01 | -46.35% | ▲49370 |
| 2024-09-30 | 0.00 | -0.03 | -540.05% | ▼817 |
| 2024-06-30 | 0.00 | -0.03 | -531.88% | ▲9369 |
| 2024-03-31 | 0.00 | -0.03 | -625.57% | ▲33653 |
| 2023-12-31 | 0.00 | -0.03 | -962.10% | ▼22020 |
| 2023-09-30 | 0.00 | -0.02 | -741.90% | ▼197745 |
| 2023-06-30 | -0.00 | -0.03 | 1235.55% | ▲167315 |
| 2023-03-31 | 0.01 | -0.02 | -437.60% | ▲34720 |
| 2022-12-31 | 0.00 | -0.03 | -784.80% | ▲11403 |
| 2022-09-30 | 0.00 | -0.03 | -898.83% | ▼13585 |
| 2022-06-30 | 0.00 | -0.02 | -762.98% | ▲5865 |
| 2022-03-31 | 0.00 | -0.02 | -821.63% | — |
| 2021-12-31 | 0.00 | -0.02 | — | — |
| 2021-09-30 | 0.00 | -0.02 | — | — |
| 2021-06-30 | 0.00 | -0.02 | — | — |
| 2021-03-31 | 0.00 | -0.02 | — | — |
| 2020-12-31 | 0.00 | -0.01 | — | — |
| 2020-09-30 | 0.00 | -0.01 | — | — |
| 2020-06-30 | 0.00 | -0.01 | — | — |
| 2020-03-31 | 0.00 | -0.01 | — | — |
| 2019-12-31 | 0.00 | -0.01 | — | — |
| 2019-09-30 | 0.00 | -0.01 | — | — |
| 2019-06-30 | 0.00 | -0.01 | — | — |
| 2019-03-31 | 0.00 | -0.01 | — | — |
| 2018-12-31 | 0.00 | -0.00 | — | — |
| 2018-09-30 | 0.00 | -0.00 | — | — |
| 2018-06-30 | 0.00 | -0.00 | — | — |
| 2018-03-31 | 0.00 | -0.00 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.